Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Inv. presentation
Quarterly results
Acq. announced

Elanco Animal Health Inc (ELAN) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/09/2023 8-K Investor presentation
Docs: "© 2023 Elanco or its affiliates This presentation contains forward - looking statements within the meaning of Section 27A of the Securities Act of 1933 and Sectio n 21E of the Securities Exchange Act of 1934 , including, without limitation , our long - term revenue and earnings growth expectations, reduction of debt and leverage, expectations regarding product launche s and related regulatory proceedings, and our industry and our operations, performance, and financial condition . Forward - looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward - looking statements relate to the fu ture, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that a..."
01/10/2022 8-K Investor presentation
Docs: "Investor Presentation of Elanco Animal Health Incorporated"
08/20/2019 8-K Investor presentation
Docs: "Share and Asset Purchase Agreement, between Bayer Aktiengesellschaft and Elanco Animal Health Incorporated",
"Elanco Announces Agreement to Acquire Bayer's Animal Health Business",
"Investor presentation"
04/26/2019 8-K Investor presentation, Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Elanco Animal Health Incorporated, Elanco Athens Inc. and Aratana Therapeutics, Inc. (including the Form of Contingent Value Rights Agreement)",
"Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus",
"Investor Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy